CELECOXIB-D7
- CAS No.
- 544686-21-7
- Chemical Name:
- CELECOXIB-D7
- Synonyms
- CELECOXIB-D7;Celecoxiβ-d7;[2H7]-Celecoxib;4-[5-[4-(methyl-d3)phenyl-2,3,5,6-d4]-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide;4-[5-[2,3,5,6-tetradeuterio-4-(trideuteriomethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide;Celecoxib D7Q: What is Celecoxib D7 Q: What is the CAS Number of Celecoxib D7 Q: What is the storage condition of Celecoxib D7 Q: What are the applications of Celecoxib D7
- CBNumber:
- CB5388385
- Molecular Formula:
- C17H7D7F3N3O2S
- Molecular Weight:
- 388.42
- MDL Number:
- MFCD08063418
- MOL File:
- Mol file
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS08,GHS09 |
---|---|
Signal word | Danger |
Hazard statements | H360-H400-H410 |
Precautionary statements | P201-P202-P273-P280-P308+P313-P391-P405-P501 |
CELECOXIB-D7 price More Price(10)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 18248 | Celecoxib-d7 ≥99% deuterated forms (d1-d7) | 544686-21-7 | 500μg | $106 | 2024-03-01 | Buy |
Cayman Chemical | 18248 | Celecoxib-d7 ≥99% deuterated forms (d1-d7) | 544686-21-7 | 1mg | $198 | 2024-03-01 | Buy |
Cayman Chemical | 18248 | Celecoxib-d7 ≥99% deuterated forms (d1-d7) | 544686-21-7 | 5mg | $826 | 2024-03-01 | Buy |
TRC | C251004 | Celecoxib-d7 | 544686-21-7 | 1mg | $230 | 2021-12-16 | Buy |
Medical Isotopes, Inc. | D32648 | Celecoxib-d7(tolyl-d7) | 544686-21-7 | 0.01g | $895 | 2021-12-16 | Buy |
CELECOXIB-D7 Chemical Properties,Uses,Production
Description
Celecoxib-d7 is intended for use as an internal standard for the quantification of celecoxib by GC- or LC-MS. Celecoxib is a selective inhibitor of COX-2 (IC50s = 22.9 and 0.05 μM for COX-1 and COX-2, respectively). It displays chemopreventive activity in multiple tumor types via proapoptotic effects that are independent of COX-2 inhibition. Formulations containing celecoxib have been used in the treatment of inflammation while circumventing the gastrointestinal toxicity associated with traditional non-sterodial anti-inflammatory drugs, however, the use of celecoxib has been tempered due to its ability to induce adverse cardiovascular events.
Uses
Celecoxib-d7 is the labeled analogue of Celecoxib (C251000), a selective cyclooxygenase-2 (COX-2) inhibitor. Anti-inflammatory. Used in treatment of familial adenomatous polyposis.
CELECOXIB-D7 Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28180 | 58 |
Shaanxi Dideu Medichem Co. Ltd | +86-29-87569266 15319487004 | 1015@dideu.com | China | 4088 | 58 |
sgtlifesciences pvt ltd | +8617013299288 | dj@sgtlifesciences.com | China | 12382 | 58 |
Hunan Jibang Biological Technology Co., LTD | +8613776644403 | sales02@kingboomtech.com | China | 1806 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3136 | 58 |
Zibo Hangyu Biotechnology Development Co., Ltd | +86-0533-2185556 +8617865335152 | Mandy@hangyubiotech.com | China | 10991 | 58 |
Guangzhou PI PI Biotech Inc | 020-81716320 +86-13602409664 | Sales@pipitech.com | China | 3635 | 55 |
J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 | jkinfo@jkchemical.com | China | 96815 | 76 |
Clearsynth Labs Limited | +91-22-26355700 | info@clearsynth.com | India | 9685 | 58 |
Cato Research Chemicals Inc. | 020-81960175 | min.he@cato-chem.com | China | 1958 | 55 |